Pars Plana Vitrectomy versus Intravitreal Injection of Ranibizumab in the Treatment of Diabetic Macular Edema Associated with Vitreomacular Interface Abnormalities

Figure 4

Sample cases from group II. Case 1: (a) baseline OCT scan of DME with concurrent ERM, CDVA 1.0; and (b) OCT scan 6 months after PPV showing marked improvement in central macular thickness, CDVA improved to 0.77. Case 2: (c) baseline OCT scan of DME with concurrent ERM, CDVA 0.82; and (d) OCT scan 6 months after PPV showing worsening of cystoid macular edema, CDVA dropped to 0.92.

(a)

(b)

(c)

(d)